Announcement

Collapse
No announcement yet.

Int J Biol Sci. Traditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Int J Biol Sci. Traditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective


    Int J Biol Sci. 2020 Mar 15;16(10):1708-1717. doi: 10.7150/ijbs.45538. eCollection 2020.
    Traditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective.


    Yang Y1, Islam MS1, Wang J1, Li Y1, Chen X1.

    Author information




    Abstract

    Currently, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2, formerly known as 2019-nCoV, the causative pathogen of Coronavirus Disease 2019 (COVID-19)) has rapidly spread across China and around the world, causing an outbreak of acute infectious pneumonia. No specific anti-virus drugs or vaccines are available for the treatment of this sudden and lethal disease. The supportive care and non-specific treatment to ameliorate the symptoms of the patient are the only options currently. At the top of these conventional therapies, greater than 85% of SARS-CoV-2 infected patients in China are receiving Traditional Chinese Medicine (TCM) treatment. In this article, relevant published literatures are thoroughly reviewed and current applications of TCM in the treatment of COVID-19 patients are analyzed. Due to the homology in epidemiology, genomics, and pathogenesis of the SARS-CoV-2 and SARS-CoV, and the widely use of TCM in the treatment of SARS-CoV, the clinical evidence showing the beneficial effect of TCM in the treatment of patients with SARS coronaviral infections are discussed. Current experiment studies that provide an insight into the mechanism underlying the therapeutic effect of TCM, and those studies identified novel naturally occurring compounds with anti-coronaviral activity are also introduced.
    ? The author(s).



    KEYWORDS:

    SARS-CoV-2; Traditional Chinese Medicine (TCM); coronavirus pneumonia


    PMID:32226288PMCID:PMC7098036DOI:10.7150/ijbs.45538


  • #2
    Merci, alors que les m?dicaments manquent en France ou ailleurs, et par respect pour la culture chinoise, quand on ?crit ceci :
    "greater than 85% of SARS-CoV-2 infected patients in China are receiving Traditional Chinese Medicine"

    je veut des d?tails, donc la nature exacte, des prescriptions et des patients, car ces prescriptions se doivent d'?tre individualis?es d'une part , d'autre part je souhaiterai savoir comment le stock de prescription a ?t? constitu? ?

    Dit autrement, si je respecte certains ?crits , je veut les faits ...

    Comment


    • #3
      T?tram?thylpyrazine: un m?dicament prometteur pour le traitement de l'hypertension pulmonaire


      https://bpspubs.onlinelibrary.wiley....1111/bph.15000

      Comment

      Working...
      X